Daiichi Sankyo and Merck report phase 2 trial results for lung cancer drug
CIMG Inc. (NASDAQ:IMG) announced Thursday it has received a written notification from the Nasdaq Hearings Panel granting the company’s request to continue its listing on The Nasdaq Stock Market, provided it meets certain conditions.
According to a press release statement based on a September 2 letter from the Panel, CIMG Inc. must regain compliance with Nasdaq’s Periodic Filing Rule and Equity Rule by September 30, 2025. The company is also required to promptly notify Nasdaq of any significant events that may affect its compliance status during the exception period.
The Panel’s decision followed a hearing held on August 14, where CIMG Inc. addressed previous deficiencies related to Nasdaq Listing Rules 5550(a)(2), 5250(c)(1), and 5550(b)(1), known as the Bid Price Rule, Periodic Filing Rule, and Equity Rule. The company presented a compliance plan to the Panel, which included current and future capital raises and new revenue contracts.
The Nasdaq Hearings Advisor indicated that the Panel considered the full record, which included CIMG Inc.’s business description, financial data, market information, and compliance history.
The notification also stated that the Nasdaq Listing and Hearing Review Council may review the Panel’s decision within 45 calendar days. If a review is initiated, the Council may affirm, modify, reverse, dismiss, or remand the decision, and CIMG Inc. would be notified if the matter is called for review.
CIMG Inc. is incorporated in Nevada and its principal executive offices are located in Hong Kong. Its common stock trades on The Nasdaq Stock Market under the symbol IMG.
All information is based on a statement issued in a recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.